Search
New advances toward safely targeting immune cells to pediatric brain tumors
- OPACC
- May 1, 2020
- 1 min read
Stanford scientists have taken important steps toward figuring out how to use immune therapy for a group of severe pediatric brain tumors known as atypical teratoid/rhabdoid tumors.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments